Valuation Collegium Pharmaceutical, Inc. Boerse Muenchen

Stocks

Market Closed - Boerse Muenchen 00:44:15 08/10/2026 +04			5-day change	1st Jan Change
19.50 ^EUR	0.00%		+0.52%	-53.57%

09-23	Collegium's Durable Cash Flow From Pain Portfolio Poised to Support Further Business Development, Oppenheimer Says	MT
09-23	Oppenheimer Initiates Collegium Pharmaceutical at Outperform With $50 Price Target	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	713.9	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-51.22%	-	-
Enterprise Value (EV) ¹	650	778.9	1,004	924	1,464	1,565	1,267	713.9
Change	-	19.82%	28.87%	-7.95%	58.4%	6.95%	-19.06%	-43.65%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	13.2x	6.59x	5.14x
PBR	-	-	-	-	-	2.54x	2x	-
PEG	-	0x	-0x	0.3x	-3.83x	-3.26x	0x	0.2x
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	0.85x	0.84x	0.83x
EV / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	1.87x	1.5x	0.83x
EV / EBITDA	5.49x	2.93x	2.74x	2.3x	3.18x	3.43x	3.05x	1.8x
EV / EBIT	36.9x	23.4x	6.01x	5.44x	8.15x	3.49x	3.15x	1.9x
EV / FCF	-	-	3.66x	4.54x	4.47x	5.56x	3.53x	1.81x
FCF Yield	-	-	27.3%	22%	22.4%	18%	28.3%	55.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	1.66	3.33	4.265
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	835.6	846.5	859.7
EBITDA ¹	118.3	266	367	401.2	460.5	456.1	415	396.4
EBIT ¹	17.63	33.32	167	169.9	179.6	448.9	402.1	376.5
Net income ¹	71.52	-25	48.16	69.19	62.87	43.25	89.53	159.7
Net Debt ¹	-	-	-	-	-	851.4	553.1	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	21.93	21.93	21.93
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	32,556	-	-
Announcement Date	24/02/22	23/02/23	22/02/24	27/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.87x	11.93x	24.1x	0.6%	1,032B
JOHNSON & JOHNSON	28.34x	6.29x	17.98x	2.1%	614B
ABBVIE INC.	37.73x	7.89x	16.32x	2.6%	471B
MERCK & CO., INC.	103.26x	5.79x	24.59x	2.4%	350B
ROCHE HOLDING AG	19.01x	4.63x	11.48x	2.86%	337B
NOVARTIS AG	19.87x	5.19x	12.84x	3.07%	268B
ASTRAZENECA PLC	20.52x	4.22x	12.02x	2.1%	246B
AMGEN INC.	25.43x	6.65x	11.85x	2.51%	218B
GILEAD SCIENCES, INC.	-43.62x	6.37x	24.89x	2.28%	179B
Average	27.04x	6.55x	17.34x	2.28%	412.76B
Weighted average by Cap.	32.24x	7.67x	18.71x	1.95%